Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wanying Wang

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Cancer Immunology, Immunotherapy : CII|June 7, 2021
ICI plus chemotherapy prolonged survival over ICI alone in patients with previously treated advanced NSCLCShiqi Mao, Fei Zhou, Yiwei Liu, et al.
International Journal of Cancer|September 5, 2022
Special issue "The advance of solid tumor research in China": FGFR4 alterations predict efficacy of immune checkpoint inhibitors in nonsmall cell lung cancerGuanghui Gao, Longgang Cui, Fei Zhou, et al.
Thoracic Cancer|February 24, 2024
Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung diseaseChuchu Shao, Xinxin Zhi, Shiqi Mao, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2023
Association of PD-L1 expression with efficacy of alectinib in advanced NSCLC patients with ALK fusionYingying Pan, Xinyu Liu, Wei Zhang, et al.
Translational Lung Cancer Research|March 15, 2021
Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutationsShuo Yang, Yan Wang, Chao Zhao, et al.
Chinese Medical Journal|March 15, 2023
Outcome comparison of pyrotinib with current standard of care in the second/third line setting in advanced non-small cell lung cancer patients with HER2 mutationShiqi Mao, Libo Luo, Shuo Yang, et al.
Gastroenterology|December 20, 2024
Effect of an Endoscopy Screening on Upper Gastrointestinal Cancer Mortality: A Community-Based Multicenter Cluster Randomized Clinical TrialChangfa Xia, He Li, Yongjie Xu, et al.
Cancer Cell|June 28, 2024
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancerCaicun Zhou, Chongyang Li, Libo Luo, et al.
The Journal of Experimental Medicine|January 29, 2024
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activationZhen Qin, Meiting Yue, Shijie Tang, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Cancer Immunology, Immunotherapy : CII|June 7, 2021
ICI plus chemotherapy prolonged survival over ICI alone in patients with previously treated advanced NSCLCShiqi Mao, Fei Zhou, Yiwei Liu, et al.
International Journal of Cancer|September 5, 2022
Special issue "The advance of solid tumor research in China": FGFR4 alterations predict efficacy of immune checkpoint inhibitors in nonsmall cell lung cancerGuanghui Gao, Longgang Cui, Fei Zhou, et al.
Thoracic Cancer|February 24, 2024
Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung diseaseChuchu Shao, Xinxin Zhi, Shiqi Mao, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2023
Association of PD-L1 expression with efficacy of alectinib in advanced NSCLC patients with ALK fusionYingying Pan, Xinyu Liu, Wei Zhang, et al.
Translational Lung Cancer Research|March 15, 2021
Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutationsShuo Yang, Yan Wang, Chao Zhao, et al.
Chinese Medical Journal|March 15, 2023
Outcome comparison of pyrotinib with current standard of care in the second/third line setting in advanced non-small cell lung cancer patients with HER2 mutationShiqi Mao, Libo Luo, Shuo Yang, et al.
Gastroenterology|December 20, 2024
Effect of an Endoscopy Screening on Upper Gastrointestinal Cancer Mortality: A Community-Based Multicenter Cluster Randomized Clinical TrialChangfa Xia, He Li, Yongjie Xu, et al.
Cancer Cell|June 28, 2024
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancerCaicun Zhou, Chongyang Li, Libo Luo, et al.
The Journal of Experimental Medicine|January 29, 2024
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activationZhen Qin, Meiting Yue, Shijie Tang, et al.
Pageof 8